REACH Orphan Substances Consortium SRL
REACH Orphan Substances Consortium reported total assets of €1.19m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jul 2026).
By total assets for 2025, REACH Orphan Substances Consortium ranks among the 200 largest of the 1,785 companies in its sector (NACE 7499) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of REACH Orphan Substances Consortium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets -6 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
REACH Orphan Substances Consortium's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 03 Jul 2024
- Year ended 31 Dec 2022filed on 17 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
REACH Orphan Substances Consortium's financial analysis
- Solvency0.5%sector median: 55.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of REACH Orphan Substances Consortium
1 active director(s) in the register.
REACH Orphan Substances Consortium's shareholders and holdings →REACH Orphan Substances Consortium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0630.838.609
- VAT number
- BE0630838609
- Peppol
- Registered · 0208:0630838609 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 May 2015
- Registered office
- 2350 Vosselaar
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Other liberal professions and professional, scientific and technical activities n.e.c. (NACE 74999)
REACH Orphan Substances Consortium (SRL) has been based in Vosselaar since 2015, active in: other liberal professions and professional, scientific and technical activities n.e.c.. For 2025, it reports a net profit of — and equity of 6,200 €; its revenue is not published. Its solvency stands at 0.5%, below the median of its sector (55.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to REACH Orphan Substances Consortium
Companies in the same business, of comparable size and area, outside its group.
- Care For Future Group All other professional, scientific and technical activities n.e.c. Beringen · balance sheet €7.47m
- Louarte Activities of holding companies Wemmel · balance sheet €1.28m
- Kieboom & Partners All other professional, scientific and technical activities n.e.c. Kalmthout · balance sheet 97,211 €
- TCV Services All other professional, scientific and technical activities n.e.c. Lier · balance sheet 320,015 €
- Cuypers Consult Other business support service activities n.e.c. Kasterlee · balance sheet 275,997 €
- DEVit³ All other professional, scientific and technical activities n.e.c. Zandhoven · balance sheet 146,512 €
- Guy Security Consultancy All other professional, scientific and technical activities n.e.c. Antwerp · balance sheet 995,991 €
- B.I.E. Van Herck Other business support service activities n.e.c. Lille · balance sheet 656,710 €
Frequently asked questions about REACH Orphan Substances Consortium
What is the revenue of REACH Orphan Substances Consortium?
REACH Orphan Substances Consortium files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of REACH Orphan Substances Consortium?
In Belgium, the VAT number is the company number prefixed with BE: BE0630838609 for REACH Orphan Substances Consortium, if the company is VAT-registered. Its company number (CBE) is 0630.838.609.
Where is the registered office of REACH Orphan Substances Consortium?
According to the CBE register, the registered office of REACH Orphan Substances Consortium is in 2350 Vosselaar.
What is the equity of REACH Orphan Substances Consortium?
At the close of the 2025 financial year, the equity of REACH Orphan Substances Consortium amounts to 6,200 €, a solvency of 0.5% of total assets.
Who manages REACH Orphan Substances Consortium?
The register lists 1 active mandates at REACH Orphan Substances Consortium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is REACH Orphan Substances Consortium within its sector?
By total assets for 2025, REACH Orphan Substances Consortium ranks among the 200 largest of the 1,785 companies in its sector (NACE 7499) in Belgium that filed accounts for that financial year.
The full file of REACH Orphan Substances Consortium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →